Enlivex Doses First Patient in Placebo-Controlled Phase IIb Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients with ARDS

by NASDAQ Market News September 22, 2021

NASDAQ Market News
Click here to email author

Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-For-Profit Price for Donation to Poorest Countries

Global Contrast Enhanced Ultrasound Market (2021 to 2028) – Size, Share & Trends Analysis Report

Ads